Written by the Peptide Trades team from public sources and community testing practice. Not medical advice.
Tirzepatide is supplied through two very different channels. One is the licensed pharmacy system, where a prescription is required. The other is the research chemical trade, where products are labelled for laboratory work and are not regulated as medicines. This page explains how the pharmacy side gets its raw material, using public records and documents shared by one pharmacy.
What is a 503a/b Pharmacy?
The name comes from two sections of US drug law that cover compounding. A 503A pharmacy is licensed to mix a medicine for a named patient when a prescriber orders it. A 503B outsourcing facility works at a larger scale and supplies hospitals, clinics and other providers.
While tirzepatide sat on the FDA shortage list, these pharmacies were allowed to make their own versions of it. That changed when the agency declared on 19 December 2024 that the shortage of the active ingredient was over. The FDA set wind-down periods ending in February 2025 for 503A pharmacies and March 2025 for 503B facilities. After that point, the prescription route for tirzepatide is the branded products, Mounjaro and Zepbound.
Who are their API sources?
A compliant compounder cannot buy its API from just anyone. The bulk tirzepatide it uses has to come from a manufacturer or reseller that is registered with the FDA.
Those registrations are public. You can browse them in the FDA NDC directory of unfinished products. When this guide was first put together in December 2024, the bulk powder listed there was made in China. The US names on the list looked like wholesale resellers. One further labeler was based in India, though no product from it had been seen in the US at that time.
Red Rock Pharmacy, a 503A compounder in Utah, sent supplier COAs when asked. The documents show that two of its sources are Genohope and Avlantis. Both appear on the FDA list of registered tirzepatide labelers.


Who are the FDA-Registered Labelers?
This chart groups every registered labeler by country and by its FDA market category. China dominates the bulk supply. Only seven labelers on the list offer tirzepatide in lots of one kilogram or more. Our reading is that most of the rest buy finished raw powder and sell it on, though the records do not state this directly.

Cumulative Growth of Registered Labelers
Since January 2023 the number of registered tirzepatide labelers has climbed month after month. China accounts for most of that growth. The US count has stayed small, which fits the picture of US firms acting as middlemen. The one US company the original authors knew of that makes tirzepatide API itself is Corden Pharma, which works under licence from Eli Lilly.

What form of tirzepatide are they using?
In its reply, Red Rock Pharmacy said it works from tirzepatide in its base form, bought as raw powder. It does not buy or use lyophilized (freeze-dried) tirzepatide. That is the reverse of the research chemical trade, where vials of lyophilized powder are the usual format.

Found an error, a dead source link or a newer record? Tell the Peptide Trades team and we will review the page.